Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: PERFUSION MEDICAL LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-09-15 to 2026-01-14
Current total value of award: $2986772.93
Description: DHA SBIR D2P II H2D-0122 IND-ENABLED STUDIES OF PM-208 A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC MEDICAL R AND D